Michelle Fay Cortez
Biohacking a Ripped Frog
Data on Fish-Oil Pill May Justify Amarin's Surging Stock Price
Medtronic, which sells about $2 billion worth of diabetes devices a year, has come to regard the DIY community as allies.
There’s clear evidence that male rats exposed to high levels of radiation used in mobile phones developed cancerous heart tumors.
Alzheimer's Drug New Data Shows More Study Likely Needed
Opioid Alternative From Pfizer and Lilly Shows Promise in Study
Biotech Investor Ousted Over Harassment Claims Sues
Novel Cell Therapy Offers Promise for Deadly Brain Infection
Vericel’s FDA-approved MACI procedure has a small but valuable audience.
Amarin's 475% Surge Leaves Its Holders Flush and Sellers Crushed
Roche Left Seeking a Niche as Merck Dominates Lung-Cancer Market
Medtronic Agrees to Buy Mazor Robotics in $1.6 Billion Deal
This Cartridge of Plastic Beads Can Filter Blood During Surgery
Liu Qiangdong flew home to China not long after his arrest, raising questions about why he was freed so quickly.
A Year After Cancer Milestone, Novartis’s Barrett Talks Next Steps
U.S. FDA is warning doctors, patients that few widely used diabetes drugs may, in some rare cases, cause a Fournier’s gangrene.
Suicides and deaths from drug overdoses are killing more people in the U.S. than diabetes is.
The biggest technical hurdle for Onpattro was getting it into the liver cell’s cytoplasm.
Alnylam Wins First U.S. Drug Approval in Rare Genetic Disease
ICU Medical Drops After Report Smiths May Walk From Deal Talks